Replies to post #50471 on Hemp Inc (HEMP)

[Det_Robert_Thorne]

If Perlowin is reading this board daily ...

... then maybe he will remember this post I wrote in July, 2014 about the then unreported 2Q/14 results (HEMP filed a month later):

Why? HEMP will report lower revenue in 2Q

The fact that HEMP announced only two consulting deals in 2Q/14, coupled with the smaller number of shares paid by the clients signed in 1Q/14 at lower prices, point to lower revenues in the last quarter than in the first.

If properly marked-to-market, the value of the shares held will fall dramatically, and more than likely, there will be additional debt because of the purchase of the decorticator.

Why wouldn't HEMP go lower still?

BTW, if revenue had been up from 1Q/14, Perlowin would be talking about it by now, and he isn't.

When HEMP did finally report 2Q/14 results:

1) Revenues were down 57%
2) EPS was down 42%
3) HEMP took a $3.3M writedown on the stock held on the balance sheet
4) Outstanding shares increased by 390M, with 280M being Preferred K shares converted to common
5) The amount of loans due to Perlowin had increased by more than $600K from 1Q/14

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105469668

Apparently, I understand his business well enough to predict the overall performance of the company.

I'll be correct about 3Q/14, too.

1) Lower revenue
2) Another writedown (at least, there should be, based on stock prices)
3) More dilution

And based on the disorder in the market for Kenaf, correct about that as well.